Results 161 to 170 of about 23,240 (230)

Serotonergic Suppression of Sustained Synaptic Responses in Rat Oculomotor Neural Integrator Networks. [PDF]

eNeuro
Saito Y, Sugimura T.
europepmc   +1 more source

Searching for Mechanisms of Analgesic Activity in the Group of 1<i>H</i>-Pyrrolo[3,4-<i>c</i>]pyridine-1,3(2<i>H</i>)-dione Derivatives-In Vitro and In Vivo Studies. [PDF]

Methods Protoc
Dziubina A, Szkatuła D, Szafarz M, Siwek A, Kowalski M, Gdula-Argasińska J.   +5 more
europepmc   +1 more source

Differential modulation of feedforward inhibition reflects topographic organization in the olfactory system. [PDF]

Nat Commun
Jonaitis J, Mazri MFEB, Hageter JW, Cook O, Sizemore TR, Bennett MM, Ralston JD, Salman F, Fletcher EJ, Matheny DE, Renton J, Ramachandra KL, Horstick EJ, Dacks AM.   +13 more
europepmc   +1 more source

Intranasal Galanin(1-15) influences depression- and anxiety-related behaviors through sex-dependent mechanisms in rats. [PDF]

Biol Sex Differ
Cantero-García N, Flores-Burgess A, Flores-Gómez M, Pineda-Gómez JP, Millón C, Díaz-Cabiale Z.   +5 more
europepmc   +1 more source

The role of peripheral serotonin in SARS-CoV-2 infectivity, COVID-19 treatment and long COVID. [PDF]

Immunol Cell Biol
Thorpe DW, Jones LA, Martin AM, Coleman RA, Allman C, Peterson RA, Keating DJ.   +6 more
europepmc   +1 more source

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation. [PDF]

Molecules
Kaczor AA, Zięba A, Karcz T, Jastrzębski MK, Szczepańska K, Laitinen T, Castro M, Kędzierska E.   +7 more
europepmc   +1 more source

Antioxidant and neuromodulatory effect of gallic acid prevents anxiety-like symptoms of omeprazole. [PDF]

RSC Adv
Samad N, Manzoor N, Saleem S, Khaliq S, Ejaz U, Arshad M, Ahmad S, Khatab Abbasi BB, Irfan A, Bin Jardan YA.   +9 more
europepmc   +1 more source

Oxygen-dependent regulation of serotonin receptor <i>5-HT</i> _<i>1A</i> in hypoxic response and flight performance in bumblebees, <i>Bombus terrestris</i>. [PDF]

iScience
Jiang C, Meng P, Du X, Sun Y, Huang X, Chen B.   +5 more
europepmc   +1 more source

No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of View. [PDF]

Neurol Int
Müller T.
europepmc   +1 more source

Mapping the path to recovery: the intersection of cortical thickness reductions and serotonin transporter expression in anorexia nervosa. [PDF]

Mol Psychiatry
Tarchi L, Doose A, Bernardoni F, King JA, Hellerhoff I, Bahnsen K, Hess A, Dörfler A, Horndasch S, Castellini G, Ricca V, Marxen M, Roessner V, Thompson PM, Ehrlich S.   +14 more
europepmc   +1 more source